Pseudomyxoma peritonei

Pseudomyxoma peritonei (PMP) is an uncommon "bor-derline malignancy" generally arising from a perforated appendiceal epithelial tumour. Optimal treatment involves a combination of cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Controversy persists reg...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastrointestinal oncology 2010-01, Vol.2 (1), p.44-50
Main Authors: Bevan, Katharine E, Mohamed, Faheez, Moran, Brendan J
Format: Article
Language:English
Subjects:
Appendiceal
belly
Borderline
chemotherapy
Cytoreductive
Heated
intraperitoneal
Jelly
malignancy
mucinous
Peritoneal
peritonei
Pseudomyxoma
surgery
Topic Highlight
tumour
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pseudomyxoma peritonei (PMP) is an uncommon "bor-derline malignancy" generally arising from a perforated appendiceal epithelial tumour. Optimal treatment involves a combination of cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Controversy persists regarding the pathological classification and its prognostic value. Computed tomography scanning is the optimal preoperative staging technique. Tumour marker elevations correlate with worse prognosis and increased recurrence rates. Following CRS with HIPEC, 5-year survival ranges from 62.5% to 100% for low grade, and 0%-65% for high grade disease. Treat-ment related morbidity and mortality ranges from 12 to 67.6%, and 0 to 9%, respectively. Surgery and HIPEC are the optimal treatment for PMP which is at best a "borderline" peritoneal malignancy.
ISSN:1948-5204
1948-5204
DOI:10.4251/wjgo.v2.i1.44